Please login to the form below

Not currently logged in
Email:
Password:

Elan

This page shows the latest Elan news and features for those working in and with pharma, biotech and healthcare.

Teva planning fresh offer for Mylan, say sources

Teva planning fresh offer for Mylan, say sources

Perrigo meanwhile is in the midst of its own buying spree having bought Belgium's Omega Pharma last November and Elan in 2013 and has just been linked to a possible

Latest news

More from news
Approximately 12 fully matching, plus 121 partially matching documents found.

Latest Intelligence

  • Deal Watch February 2017 Deal Watch February 2017

    The largest of these was Perrigo's divestment to Royalty Pharma of its royalty stream from Biogen's global sales of Tysabri (natalizumab), the multiple sclerosis antibody originally developed by Elan,

  • Pharma deals during November 2014 Pharma deals during November 2014

    This follows Perrigo's acquisition of Elan in July last year for $8.6bn.

  • Pharma deals during September 2014 Pharma deals during September 2014

    2011. Alkermes. Elan. Ireland. 2012. Jazz. Azur. Ireland. 2013. Liberty Global. ... Virgin Media. UK. 2013. Actavis. Warner Chilcott. Ireland. 2013. Perrigo. Elan.

  • Pharma deals during July 2014 Pharma deals during July 2014

    In the last three days of July 2013, nine deals were announced with a total value of just over $12bn, of which Irish-based Elan's $8.6bn acquisition by Perrigo ... This time it is AbbVie's acquisition of Shire, albeit for a much bigger price tag than Elan

  • Pharma deals during March 2014 Pharma deals during March 2014

    This follows on from several other acquisitions of Irish entities, which result in US companies paying Irish corporation tax, eg the acquisition by Perrigo of Elan and Actavis' acquisition of Warner

More from intelligence
Approximately 0 fully matching, plus 12 partially matching documents found.

Latest appointments

More from appointments
Approximately 0 fully matching, plus 6 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
COUCH.

WE ARE COUCH – a full service medical communications agency. We are a trusted partner; always striving to help make...

Latest intelligence

The threat of antimicrobial resistance
Why this issue is such a fundamental challenge...
Meet the CEO behind ReNeuron’s cutting-edge stem cell therapies
Blue Latitude Health speaks to Olav Hellebo, CEO of ReNeuron, to find out about the biotech’s latest innovation in stem cell therapy and to learn his perspective on navigating the...
Unique forum will unite NHS and industry to drive innovation
HSJ Life Sciences Forum will explore key NHS challenges and debate future of medicines, by Sarah Eglington, Client Services Director at Wilmington Healthcare...

Infographics